A biomarker of collagen type I degradation is associated with cardiovascular events and mortality in patients with atherosclerosis.

MLA

Holm Nielsen, S., et al. “A Biomarker of Collagen Type I Degradation Is Associated with Cardiovascular Events and Mortality in Patients with Atherosclerosis.” Journal of Internal Medicine, vol. 285, no. 1, Jan. 2019, pp. 118–23. EBSCOhost, https://doi.org/10.1111/joim.12819.

APA

Holm Nielsen, S., Tengryd, C., Edsfeldt, A., Brix, S., Genovese, F., Bengtsson, E., Karsdal, M., Leeming, D. J., Nilsson, J., & Goncalves, I. (2019). A biomarker of collagen type I degradation is associated with cardiovascular events and mortality in patients with atherosclerosis. Journal of Internal Medicine, 285(1), 118–123. https://doi.org/10.1111/joim.12819

Chicago

Holm Nielsen, S, C Tengryd, A Edsfeldt, S Brix, F Genovese, E Bengtsson, M Karsdal, D J Leeming, J Nilsson, and I Goncalves. 2019. “A Biomarker of Collagen Type I Degradation Is Associated with Cardiovascular Events and Mortality in Patients with Atherosclerosis.” Journal of Internal Medicine 285 (1): 118–23. doi:10.1111/joim.12819.